Camden National Bank’s Novartis AG Position
Does Camden National Bank own Novartis AG (NVSN)? Yes — 70.2K shares worth $11M (+1.45% of its 13F portfolio) as of Q1 2026, down from 70.9K shares the prior filed quarter.
Position Value
$11M
Q1 2026
Shares
70.2K
% of Portfolio
+1.45%
Quarters Held
29
currently held
Position History NVSN
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 70.2K | $11M | +1.45% |
| Q4 2025 | 70.9K | $10M | +1.34% |
| Q3 2025 | 70.6K | $9M | +1.27% |
| Q2 2025 | 71.1K | $9M | +1.24% |
| Q1 2025 | 72.3K | $8M | +1.20% |
| Q4 2024 | 73.5K | $7M | +1.07% |
| Q3 2024 | 73.9K | $9M | +1.22% |
| Q2 2024 | 75.4K | $8M | +1.24% |
| Q1 2024 | 65.1K | $6M | +1.11% |
| Q4 2023 | 66.5K | $7M | +1.25% |
| Q3 2023 | 67.0K | $7M | +1.40% |
| Q2 2023 | 67.5K | $7M | +1.33% |
| Q1 2023 | 68.7K | $6M | +1.28% |
| Q4 2022 | 68.2K | $6,186 | +1.29% |
| Q3 2022 | 68.4K | $5M | +1.16% |
| Q2 2022 | 68.1K | $6M | +1.19% |
| Q1 2022 | 66.4K | $6M | +1.06% |
| Q4 2021 | 66.1K | $6M | +1.02% |
| Q3 2021 | 66.6K | $5M | +1.05% |
| Q2 2021 | 65.2K | $6M | +1.12% |
| Q4 2020 | 66.4K | $6M | +1.30% |
| Q3 2020 | 68.9K | $6M | +1.32% |
| Q2 2020 | 68.4K | $6M | +1.48% |
| Q1 2020 | 68.2K | $6M | +1.53% |
| Q4 2019 | 77.0K | $7M | +1.48% |
| Q3 2019 | 74.4K | $6M | +1.41% |
| Q2 2019 | 73.6K | $7M | +1.55% |
| Q1 2019 | 73.0K | $7M | +1.70% |
| Q4 2018 | 72.3K | $6M | +1.71% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Camden National Bank’s full portfolio or all institutional holders of NVSN.